Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

NRX Pharmaceuticals, Inc.

NASDAQ: NRXP · Life Sciences · 6 alerts · CIK 1719406

Share price
$2.15Close, Nov 16
Market cap
$93.1M
Shares outstanding
43.3MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All NRX Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:45 PM ET 10-Q
Financial Results

NRX Pharmaceuticals Q3 2026 Results: Net Loss of $2.17M, Loss Narrows

NRX Pharmaceuticals reported a net loss of $20.1 million for the nine months ended September 30, 2026, an improvement from the $29.0 million loss in the prior year period. The company significantly increased its cash position to $19.8 million through various equity offerings, while net patient service revenue grew to $3.3 million.

Key figure
Net loss $2.17M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.